R. Chakraverty

N. Russell, I. Kayani, S. Mackinnon, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A single wave of monocytes is sufficient to replenish the long-term Langerhans cell network after immune injury

Clare L. Bennett, S. Henderson, J. Strid, 2019, bioRxiv.

Role of dendritic cells in graft-versus-host disease.

R. Chakraverty, F. Clark, 2002, Journal of hematotherapy & stem cell research.

The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.

M. Sykes, R. Chakraverty, 2007, Blood.

The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype

T. Luong, Andrew Hall, R. Chakraverty, 2019, Front. Immunol..

The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype

T. Luong, Andrew Hall, R. Chakraverty, 2019, bioRxiv.

Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs.

M. Sykes, T. Means, A. Luster, 2005, International immunology.

Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase

D. Zehnder, J. Adams, M. Hewison, 2004, Molecular and Cellular Endocrinology.

prereceptor amplification of glucocorticoid Cell-intrinsic regulation of murine dendritic cell function and survival by

Clare L. Bennett, F. Fallah-Arani, G. Lavery, 2014 .

Cell-intrinsic regulation of murine dendritic cell function and survival by prereceptor amplification of glucocorticoid.

Clare L. Bennett, S. Henderson, F. Fallah-Arani, 2013, Blood.

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era

A. Pettitt, C. Craddock, J. Byrne, 2014, Bone Marrow Transplantation.

High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.

S. Mackinnon, K. Peggs, S. Verfuerth, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

cells recruited to the skin Langerhans cells regulate cutaneous injury by licensing CD8 effector

Clare L. Bennett, F. Geissmann, F. Fallah-Arani, 2013 .

Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin.

Clare L. Bennett, F. Geissmann, F. Fallah-Arani, 2011, Blood.

Conventional Dendritic Cells Are Required for the Activation of Helper-Dependent CD8 T Cell Responses to a Model Antigen After Cutaneous Vaccination with Lentiviral Vectors

Clare L. Bennett, Hugh D. Goold, D. Escors, 2011, The Journal of Immunology.

VectorsCutaneous Vaccination with Lentiviral T Cell Responses to a Model Antigen After for the Activation of Helper-Dependent CD8 Conventional Dendritic Cells Are Required

Clare L. Bennett, D. Escors, R. Chakraverty, 2011 .

In situ immunostimulatory functions of DC in tissues

Clare L. Bennett, R. Chakraverty, 2017 .

Monocyte-Derived Dendritic Cells Receptor and Its Ligand in Human Differential Regulation of Vitamin D

A. Eliopoulos, M. Hewison, R. Bland, 2003 .

Monocyte-Derived Dendritic Cells Receptor and Its Ligand in Human Differential Regulation of Vitamin

P. Moss, A. Eliopoulos, Evans, 2003 .

Non-myeloablative allogeneic transplantation for high-risk acute leukemia and myelodysplasia.

C. Craddock, S. Mackinnon, K. Peggs, 2001 .

Donor Lymphocyte Infusions Induce High Response Rates and Durable Salvage in Relapsed Hodgkin Lymphoma Post T Cell Depleted Allogeneic Transplantation.

K. Ardeshna, S. Mackinnon, K. Peggs, 2009 .

Allogeneic transplantation for lymphoma.

S. Mackinnon, R. Chakraverty, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy.

S. Mackinnon, H. Waldmann, D. Linch, 1999 .

Streptokinase resistance: when might streptokinase administration be ineffective?

M. Buchalter, P. Weissberg, T. Baglin, 1992, British heart journal.

Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation

S. Mackinnon, H. Waldmann, D. Linch, 2001, Bone Marrow Transplantation.

Differential regulation of vitamin D receptor and its ligand in human dendritic cells: A paracrine mechanism for regulation of antigen presentation

P. Moss, M. Hewison, R. Chakraverty, 2003 .

Stem Cell Transplantation

C. Craddock, R. Chakraverty, 2010 .

38. Stem Cell Transplantation

C. Craddock, R. Chakraverty, 2010 .

Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity

Clare L. Bennett, D. Escors, R. Chakraverty, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase.

D. Zehnder, J. Adams, M. Hewison, 2004, Molecular and cellular endocrinology.

An unexpected role for platelets in blocking Th17 differentiation.

R. Chakraverty, 2014, The Journal of clinical investigation.

Engineered To Express the Same T Cell Self-Antigen Is Reversed by CD4 T Cells CD8 T Cell Tolerance to a Tumor-Associated

M. Ahmadi, S. Xue, E. Morris, 2014 .

Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host disease

Clare L. Bennett, S. Henderson, V. Plagnol, 2018, JCI insight.

Title: Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation Overline: Transplantation Single sentence summary: Mesenchymal stromal cell apoptosis, induced in vivo by recipient

Apperley, Clare L. Bennett, F. Watt, 2018 .

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation

Clare L. Bennett, F. Watt, T. S. Cheung, 2017, Science Translational Medicine.

Expression of 11β-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells

T. Means, M. Hewison, D. Hardie, 2005 .

Expression of 11 (cid:1) -hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells

T. Means, M. Hewison, R. Chakraverty, 2005 .

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.

C. Craddock, S. Mackinnon, K. Peggs, 2002, Blood.

Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease1

C. Craddock, P. Moss, P. Mahendra, 2003, Transplantation.

Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study

F. Locatelli, F. Dawkins, Stephanie J. Lee, 2020 .

Risk‐stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia

R. Benjamin, S. Mackinnon, K. Peggs, 2013, British journal of haematology.

Natural history of EBV replication and viral load dynamics after alemtuzumab based allogeneic stem cell transplantation.

K. Peggs, R. Hough, E. Sanchez, 2021, Transplantation and cellular therapy.

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.

A. Pettitt, C. Crawley, J. Snowden, 2010, Blood.

Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation

P. Griffiths, S. Grace, S. Mackinnon, 2010, Transplantation.

The successful treatment of idiopathic thrombocytopenic purpura with the low dose non specific IgG component of anti D immunoglobulin.

R. Chakraverty, B. Boughton, N. Smith, 1990, Clinical and laboratory haematology.

The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age

P. Moss, N. Khan, L. Nayak, 2005, Clinical and experimental immunology.

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.

S. Mackinnon, K. Peggs, R. Hough, 2019, Haematologica.

reconstitution cell transplantation: potential role of Campath-1H in delaying immune High incidence of cytomegalovirus infection after nonmyeloablative stem

C. Fegan, S. Mackinnon, K. Peggs, 2008 .

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.

C. Craddock, C. Fegan, S. Mackinnon, 2002, Blood.

An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues

Charles P. Lin, Charles Lin, Ronjon Chakraverty, 2006, The Journal of experimental medicine.

A yeast model of Bloom's syndrome.

R Chakraverty, R. Chakraverty, 1999 .

A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy.

T. Marafioti, S. Quezada, K. Peggs, 2014, Blood.

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.

F. Locatelli, Stephanie J. Lee, N. Hollaender, 2021, The New England journal of medicine.

Redirection to the bone marrow improves T cell persistence and antitumor functions

Clare L. Bennett, J. Griffin, T. Means, 2018, The Journal of clinical investigation.

Dendritic cells in tissues: in situ stimulation of immunity and immunopathology.

Clare L. Bennett, Ronjon Chakraverty, R. Chakraverty, 2012, Trends in immunology.

A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury

Clare L. Bennett, S. Henderson, J. Strid, 2019, Science Immunology.

Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity

Clare L. Bennett, I. Ferrer, H. Stauss, 2020, The Journal of clinical investigation.

Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation.

Clare L. Bennett, G. Freeman, S. Henderson, 2010, The Journal of clinical investigation.

The Bloom’s Syndrome Gene Product Is a 3′-5′ DNA Helicase*

I. Hickson, R. Chakraverty, J. Karow, 1997, The Journal of Biological Chemistry.

The effect of anti-Rho(D) and non-specific immunoglobulins on monocyte Fc receptor function: the role of high molecular weight IgG polymers and IgG subclasses.

R. Chakraverty, B. Boughton, A. Simpson, 2008, Clinical and laboratory haematology.

The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: its effectiveness, safety and mechanism of action.

T. Baglin, P. Rose, R. Chakraverty, 1988, Clinical and laboratory haematology.

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

F. Bushman, S. Grace, A. Galy, 2017, Blood.

Treatment of HIV related immune thrombocytopenia.

R. Chakraverty, B. Boughton, N. Patton, 1988 .

TREATMENT OF HIV RELATED IMMUNE THROMBOCYTOPENIA

R. Chakraverty, B. Boughton, N. Patton, 1988, British journal of haematology.

Defending genome integrity during DNA replication: a proposed role for RecQ family helicases

I. Hickson, R. Chakraverty, 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.

S. Grace, S. Mackinnon, K. Peggs, 2018, Blood.

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning.

A. Mead, S. Mackinnon, K. Peggs, 2010, Blood.

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

M. Caligiuri, C. Lengerke, B. Becher, 2018, Nature Medicine.

nonmyeloablative stem cell transplantation In vivo CAMPATH-1H prevents graft-versus-host disease following

G. Morgan, S. Mackinnon, K. Peggs, 2013 .

Graft-versus-host disease: a disorder of tissue regeneration and repair.

R. Chakraverty, T. Teshima, 2021, Blood.

The Host Environment Regulates the Function of CD8+ Graft-versus-Host-Reactive Effector Cells1

F. Fallah-Arani, M. Sykes, H. Eom, 2008, The Journal of Immunology.

CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status.

S. Quezada, S. Mackinnon, K. Peggs, 2015, Blood.

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers

C. Craddock, P. Moss, L. Billingham, 2005, The Journal of experimental medicine.

Inactivation of homologous recombination suppresses defects in topoisomerase III-deficient mutants.

I. Hickson, R. Chakraverty, A. Goodwin, 2002, DNA repair.

Topoisomerase III Acts Upstream of Rad53p in the S-Phase DNA Damage Checkpoint

I. Hickson, J. Kearsey, N. Lowndes, 2001, Molecular and Cellular Biology.

CD8 T Cell Tolerance to a Tumor-Associated Self-Antigen Is Reversed by CD4 T Cells Engineered To Express the Same T Cell Receptor

W. Uckert, E. Nicholson, M. Ahmadi, 2014, The Journal of Immunology.

Tolerance to a Tumor-Associated Self-Antigen Is Reversed by CD 4 T Cells Engineered To Express the Same T Cell Receptor

W. Uckert, E. Nicholson, M. Ahmadi, 2014 .

Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party

J. Delgado, N. Kröger, S. Leprêtre, 2020, Bone Marrow Transplantation.

Graft Versus Leukemia: Current Status and Future Perspectives.

R. Chakraverty, A. O'Neill, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I Study of High-Stringency CD8 Depletion of Donor Leukocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation

S. Mackinnon, K. Peggs, M. Lowdell, 2009, Transplantation.

Depletion of CD11c+ cells in the CD11c.DTR model drives expansion of unique CD64+ Ly6C+ monocytes that are poised to release TNF-α

Clare L. Bennett, S. Henderson, T. Means, 2015, European Journal of Immunology.

Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1

Aristides G. Eliopoulos, Ronjon Chakraverty, P. Moss, 2003, The Journal of Immunology.

Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy

S. Xue, E. Morris, H. Stauss, 2016, Haematologica.

Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.

S. Mackinnon, K. Peggs, M. Lowdell, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dynamic regulation of hierarchical heterogeneity in Acute Myeloid Leukemia serves as a tumor immunoevasion mechanism

J. Gribben, C. Georgiou, W. Grey, 2020, bioRxiv.

OX40- and CD27-Mediated Costimulation Synergizes with Anti–PD-L1 Blockade by Forcing Exhausted CD8+ T Cells To Exit Quiescence

Clare L. Bennett, G. Freeman, A. Rogel, 2015, The Journal of Immunology.

Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party

J. Delgado, N. Kröger, S. Leprêtre, 2017 .

High dose therapy for the treatment of non-Hodgkin's lymphoma

R. Chopra, A. Goldstone, R. Chakraverty, 2000 .

Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect.

C. Craddock, S. Mackinnon, A. Hunter, 2001 .

Regulatory mechanisms in graft-versus-host responses.

F. Powrie, M. Edinger, R. Chakraverty, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation.

B. Schiedlmeier, S. Henson, H. Stauss, 2015, Cancer research.

Malabsorption and artificial nutrition in patients with gut GvHD post allogenic stem cell transplantation: Home parenteral nutrition affects survival significantly

R. Chakraverty, H. Kwok, K. Thomson, 2018, Clinical Nutrition.

Turning mTOR down in TCR gene therapy: the path to long-term protection?

H. Stauss, P. Veliça, R. Chakraverty, 2012 .

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

G. Morgan, S. Mackinnon, K. Peggs, 2000, Blood.

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

G. Mufti, N. Russell, J. Cavenagh, 2008, Bone Marrow Transplantation.

Long-term response in a patient with ITP following low dose anti-D immunoglobulin therapy.

R. Chakraverty, B. Boughton, N. Smith, 1989, Autoimmunity.